These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19418965)

  • 21. Controlled porosity solubility modulated osmotic pump tablets of gliclazide.
    Banerjee A; Verma PR; Gore S
    AAPS PharmSciTech; 2015 Jun; 16(3):554-68. PubMed ID: 25378281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synchronized and controlled release of metformin hydrochloride/glipizide from elementary osmotic delivery.
    Pan H; Jing H; Yang X; Pan W; Chen T
    Drug Dev Ind Pharm; 2017 May; 43(5):780-788. PubMed ID: 27278057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development, evaluation, and influence of formulation and process variables on
    Arjun N; Narendar D; Sunitha K; Harika K; Nagaraj B
    Int J Pharm Investig; 2016; 6(4):238-246. PubMed ID: 28123994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of alcohol on the release of tramadol from 24-h controlled-release formulations during in vitro dissolution experiments.
    Traynor MJ; Brown MB; Pannala A; Beck P; Martin GP
    Drug Dev Ind Pharm; 2008 Aug; 34(8):885-9. PubMed ID: 18618305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Push-pull osmotic pump for zero order delivery of lithium carbonate: development and in vitro characterization.
    Patel V; Chudasama A; Nivsarkar M; Vasu K; Shishoo C
    Pharm Dev Technol; 2012; 17(3):375-82. PubMed ID: 21284541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formulation Development and Optimization of Matrix Tablet of Tramadol Hydrochloride.
    Deb P; Singha J; Chanda I; Chakraborty P
    Recent Pat Drug Deliv Formul; 2017; 11(1):19-27. PubMed ID: 27712568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implantable biodegradable sponges: effect of interpolymer complex formation of chitosan with gelatin on the release behavior of tramadol hydrochloride.
    Foda NH; El-laithy HM; Tadros MI
    Drug Dev Ind Pharm; 2007 Jan; 33(1):7-17. PubMed ID: 17192246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, development and in vitro-in vivo study of tramadol-paracetamol inlay tablets.
    Kotta S; Bijumol C; Anitha Y; Dileep KJ; Valsala K
    Pharm Dev Technol; 2014 Feb; 19(1):1-9. PubMed ID: 23249424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and development of controlled porosity osmotic tablet of diltiazem hydrochloride.
    Shahi SR; Zadbuke NS; Gulecha B; Shivanikar SS; Shinde SB
    J Adv Pharm Technol Res; 2012 Oct; 3(4):229-36. PubMed ID: 23378944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formulation and dissolution kinetics study of hydrophilic matrix tablets with tramadol hydrochloride and different co-processed dry binders.
    Komersová A; Lochař V; Myslíková K; Mužíková J; Bartoš M
    Eur J Pharm Sci; 2016 Dec; 95():36-45. PubMed ID: 27496049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of hot-melt extrusion technology for designing an elementary osmotic pump system combined with solid dispersion for a novel poorly water-soluble antidepressant.
    Zhang X; Wang M; Li P; Wang A; Liang R; Gai Y; Liu W; Li Y; Sun K
    Pharm Dev Technol; 2016 Dec; 21(8):1006-1014. PubMed ID: 26446857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and in vitro/in vivo evaluation of vinpocetine elementary osmotic pump system.
    Ning M; Zhou Y; Chen G; Mei X
    Adv Pharmacol Sci; 2011; 2011():385469. PubMed ID: 21577257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and Evaluation of a Once-Daily Controlled Porosity Osmotic Pump of Tapentadol Hydrochloride.
    Thakkar HP; Pancholi N; Patel CV
    AAPS PharmSciTech; 2016 Oct; 17(5):1248-60. PubMed ID: 26677859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymeric matrix system for prolonged delivery of tramadol hydrochloride, part I: physicochemical evaluation.
    Ammar HO; Ghorab M; El-Nahhas SA; Kamel R
    AAPS PharmSciTech; 2009; 10(1):7-20. PubMed ID: 19132537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and evaluation of push-pull based osmotic delivery system for pramipexole.
    Wakode R; Bhanushali R; Bajaj A
    PDA J Pharm Sci Technol; 2008; 62(1):22-31. PubMed ID: 18402365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microparticulate drug delivery system containing tramadol hydrochloride for pain treatment.
    Ciurba A; Todoran N; Vari CE; Lazăr L; Al Hussein S; Hancu G
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(4):1135-42. PubMed ID: 25581980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and optimization of buspirone oral osmotic pump tablet.
    Derakhshandeh K; Berenji MG
    Res Pharm Sci; 2014; 9(4):233-41. PubMed ID: 25657794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmaceutical development of solid dispersion based osmotic drug delivery system for nifedipine.
    Kanagale P; Patel V; Venkatesan N; Jain M; Patel P; Misra A
    Curr Drug Deliv; 2008 Oct; 5(4):306-11. PubMed ID: 18855601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.
    Lin HL; Lin SY; Lin YK; Ho HO; Lo YW; Sheu MT
    Eur J Pharm Biopharm; 2008 Sep; 70(1):289-301. PubMed ID: 18539015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Micro-suspension coating method: a new approach in formulation and development of controlled porosity osmotic pump systems.
    Adibkia K; Hanaee J; Ghanbarzadeh S; Bahrami R; Shokri J
    Drug Res (Stuttg); 2014 Apr; 64(4):203-7. PubMed ID: 24026954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.